
|Articles|March 31, 2008
Two HIV drugs suspected of producing higher cardiovascular risk
FDA is looking at whether Ziagen and Videx is linked to more heart attacks.
Advertisement
A study has found that abacavir (Ziagen, GlaxoSmithKline) and didanosine (Videx, Bristol-Myers Squibb) are associated with an increased risk of heart attack. So the Food & Drug Administration has issued an early
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
4
Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options
5






























